CD79A and B-cell chronic lymphocytic leukemia: Although CLL is characterized by hypogammaglobulinemia and T cell subset changes, most patients still mounted robust antigen-specific IgG and IgA responses following SARS-CoV-2 vaccination, with titers comparable to those of HCs.